ALIGN TECHNOLOGY INC (1ALGN.MI) Stock Fundamental Analysis
BIT:1ALGN - US0162551016 - Common Stock
113.95 EUR
-1.5 (-1.3%)
Taking everything into account, 1ALGN scores 6 out of 10 in our fundamental rating. 1ALGN was compared to 58 industry peers in the Health Care Equipment & Supplies industry. 1ALGN has an excellent financial health rating, but there are some minor concerns on its profitability. 1ALGN is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make 1ALGN a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year 1ALGN was profitable.
In the past year 1ALGN had a positive cash flow from operations.
In the past 5 years 1ALGN has always been profitable.
In the past 5 years 1ALGN always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.71%, 1ALGN is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
The Return On Equity of 1ALGN (10.79%) is better than 70.69% of its industry peers.
1ALGN has a better Return On Invested Capital (11.04%) than 82.76% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ALGN is above the industry average of 8.86%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.79% | ||
| ROIC | 11.04% |
ROA(3y)6.72%
ROA(5y)13.99%
ROE(3y)11.08%
ROE(5y)21.89%
ROIC(3y)11.25%
ROIC(5y)11.65%
1.3 Margins
The Profit Margin of 1ALGN (10.29%) is better than 68.97% of its industry peers.
In the last couple of years the Profit Margin of 1ALGN has declined.
Looking at the Operating Margin, with a value of 16.45%, 1ALGN is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
In the last couple of years the Operating Margin of 1ALGN has declined.
Looking at the Gross Margin, with a value of 69.92%, 1ALGN is in the better half of the industry, outperforming 77.59% of the companies in the same industry.
1ALGN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.45% | ||
| PM (TTM) | 10.29% | ||
| GM | 69.92% |
OM growth 3Y-12.06%
OM growth 5Y-4.71%
PM growth 3Y-18.59%
PM growth 5Y-10.55%
GM growth 3Y-1.95%
GM growth 5Y-0.69%
2. Health
2.1 Basic Checks
1ALGN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, 1ALGN has less shares outstanding
Compared to 5 years ago, 1ALGN has less shares outstanding
There is no outstanding debt for 1ALGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
1ALGN has an Altman-Z score of 4.16. This indicates that 1ALGN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.16, 1ALGN is in the better half of the industry, outperforming 77.59% of the companies in the same industry.
There is no outstanding debt for 1ALGN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.16 |
ROIC/WACC1.27
WACC8.69%
2.3 Liquidity
1ALGN has a Current Ratio of 1.21. This is a normal value and indicates that 1ALGN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1ALGN (1.21) is worse than 72.41% of its industry peers.
1ALGN has a Quick Ratio of 1.08. This is a normal value and indicates that 1ALGN is financially healthy and should not expect problems in meeting its short term obligations.
1ALGN has a Quick ratio (1.08) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 3.29% over the past year.
1ALGN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.91% yearly.
The Revenue has been growing slightly by 0.56% in the past year.
Measured over the past years, 1ALGN shows a quite strong growth in Revenue. The Revenue has been growing by 10.69% on average per year.
EPS 1Y (TTM)3.29%
EPS 3Y-5.96%
EPS 5Y11.91%
EPS Q2Q%3.32%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y0.39%
Revenue growth 5Y10.69%
Sales Q2Q%-1.56%
3.2 Future
1ALGN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.92% yearly.
The Revenue is expected to grow by 7.34% on average over the next years.
EPS Next Y12.44%
EPS Next 2Y10.82%
EPS Next 3Y10.74%
EPS Next 5Y12.92%
Revenue Next Year3.65%
Revenue Next 2Y4.63%
Revenue Next 3Y5.02%
Revenue Next 5Y7.34%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.23, the valuation of 1ALGN can be described as correct.
1ALGN's Price/Earnings ratio is rather cheap when compared to the industry. 1ALGN is cheaper than 94.83% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.07. 1ALGN is valued slightly cheaper when compared to this.
1ALGN is valuated reasonably with a Price/Forward Earnings ratio of 11.67.
89.66% of the companies in the same industry are more expensive than 1ALGN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.59. 1ALGN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.23 | ||
| Fwd PE | 11.67 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1ALGN is valued cheaply inside the industry as 81.03% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ALGN indicates a rather cheap valuation: 1ALGN is cheaper than 91.38% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.38 | ||
| EV/EBITDA | 10.95 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of 1ALGN may justify a higher PE ratio.
PEG (NY)1.14
PEG (5Y)1.19
EPS Next 2Y10.82%
EPS Next 3Y10.74%
5. Dividend
5.1 Amount
No dividends for 1ALGN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ALGN (9/3/2025, 7:00:00 PM)
113.95
-1.5 (-1.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners94.76%
Inst Owner ChangeN/A
Ins Owners0.67%
Ins Owner ChangeN/A
Market Cap8.26B
Analysts77.5
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.58%
Min EPS beat(2)-2.04%
Max EPS beat(2)5.2%
EPS beat(4)2
Avg EPS beat(4)1.37%
Min EPS beat(4)-2.04%
Max EPS beat(4)5.2%
EPS beat(8)5
Avg EPS beat(8)2.64%
EPS beat(12)7
Avg EPS beat(12)-1.25%
EPS beat(16)10
Avg EPS beat(16)0.45%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-1.76%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-2.23%
Min Revenue beat(4)-2.89%
Max Revenue beat(4)-1.56%
Revenue beat(8)2
Avg Revenue beat(8)-1.78%
Revenue beat(12)3
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.52%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.08%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.23 | ||
| Fwd PE | 11.67 | ||
| P/S | 2.44 | ||
| P/FCF | 15.38 | ||
| P/OCF | 12.72 | ||
| P/B | 2.56 | ||
| P/tB | 3 | ||
| EV/EBITDA | 10.95 |
EPS(TTM)8.01
EY7.03%
EPS(NY)9.77
Fwd EY8.57%
FCF(TTM)7.41
FCFY6.5%
OCF(TTM)8.95
OCFY7.86%
SpS46.77
BVpS44.57
TBVpS37.99
PEG (NY)1.14
PEG (5Y)1.19
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.79% | ||
| ROCE | 15.93% | ||
| ROIC | 11.04% | ||
| ROICexc | 14.02% | ||
| ROICexgc | 16.95% | ||
| OM | 16.45% | ||
| PM (TTM) | 10.29% | ||
| GM | 69.92% | ||
| FCFM | 15.84% |
ROA(3y)6.72%
ROA(5y)13.99%
ROE(3y)11.08%
ROE(5y)21.89%
ROIC(3y)11.25%
ROIC(5y)11.65%
ROICexc(3y)14.94%
ROICexc(5y)15.83%
ROICexgc(3y)17.96%
ROICexgc(5y)19.34%
ROCE(3y)16.23%
ROCE(5y)16.81%
ROICexcg growth 3Y-14.88%
ROICexcg growth 5Y-21.64%
ROICexc growth 3Y-14.49%
ROICexc growth 5Y-22.73%
OM growth 3Y-12.06%
OM growth 5Y-4.71%
PM growth 3Y-18.59%
PM growth 5Y-10.55%
GM growth 3Y-1.95%
GM growth 5Y-0.69%
F-Score6
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 86.95% | ||
| Cap/Sales | 3.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 94.54% | ||
| Profit Quality | 154% | ||
| Current Ratio | 1.21 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 4.16 |
F-Score6
WACC8.69%
ROIC/WACC1.27
Cap/Depr(3y)145.51%
Cap/Depr(5y)194.24%
Cap/Sales(3y)5.1%
Cap/Sales(5y)6.34%
Profit Quality(3y)120.32%
Profit Quality(5y)97.89%
High Growth Momentum
Growth
EPS 1Y (TTM)3.29%
EPS 3Y-5.96%
EPS 5Y11.91%
EPS Q2Q%3.32%
EPS Next Y12.44%
EPS Next 2Y10.82%
EPS Next 3Y10.74%
EPS Next 5Y12.92%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y0.39%
Revenue growth 5Y10.69%
Sales Q2Q%-1.56%
Revenue Next Year3.65%
Revenue Next 2Y4.63%
Revenue Next 3Y5.02%
Revenue Next 5Y7.34%
EBIT growth 1Y-3.28%
EBIT growth 3Y-11.72%
EBIT growth 5Y5.48%
EBIT Next Year19.74%
EBIT Next 3Y10.28%
EBIT Next 5Y13.42%
FCF growth 1Y34.37%
FCF growth 3Y-6.89%
FCF growth 5Y0.82%
OCF growth 1Y3.27%
OCF growth 3Y-14.29%
OCF growth 5Y-0.24%